PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinica Medicine, Universidade Federal de Pernambuco, Recife, Brazil.\', \'Musculoskeletal System Department, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil amkakehasi@gmail.com.\', \'Rheumatology, Unifesp EPM, Sao Paulo, Brazil.\', \'Hospital Universitário de Brasilia, Universidade de Brasília, Brasilia, Brazil.\', \'Medicina, Unifesp EPM, Sao Paulo, Brazil.\', \'Hospital das Clinicas, Universidade Federal de Pernambuco, Recife, Brazil.\', \'Rheumatology, Iamspe, Sao Paulo, Brazil.\', \'Rheumatology, Fundação Hospitalar do Acre (Fundhacre), Rio Branco, Brazil.\', \'Rheumatology, Hospital Getulio Vargas, Recife, Brazil.\', \'Rheumatology, Universidade Federal da Paraiba, Joao Pessoa, Brazil.\', \'Rheumatology, UERJ, Rio de Janeiro, Brazil.\', \'Musculoskeletal System Department, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\', \'Rheumatology, Universidade Federal do Amazonas, Manaus, Brazil.\', \'Rheumatology, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.\', \'Rheumatology, UNICAMP, Campinas, Brazil.\', \'Rheumatology, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.\', \'Department of Rheumatology, Universidade Federal do Paraná Hospital de Clínicas, Curitiba, Brazil.\', \'Rheumatology, FACISB, Barretos, Brazil.\', \'Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil.\', \'Rheumatology, Fundação Faculdade Regional de Medicina de São José do Rio Preto (Hospital de Base), Ribeirão Preto, Brazil.\', \'Rheumatology, UNIMED Fortaleza - Ceará, Fortaleza, Brazil.\', \'Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.\', \'Pediatric immunology and rheumatology, FACISB, Barretos, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00146110.1136/rmdopen-2020-001461
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 33510041
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
?:title
  • High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33510041>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33510041>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all